Turn Therapeutics Inc. (TTRX)

Turn Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023
Net Income	-2.56	-1.77	-2.29
Depreciation & Amortization	0.05	0.05	0.04
Share-Based Compensation	-	0.35	0.64
Other Operating Activities	0.9	0.01	0.23
Operating Cash Flow	-1.6	-1.36	-1.38
Capital Expenditures	-0.08	-0.1	-0.04
Investing Cash Flow	-0.08	-0.1	-0.04
Share Issuance / Repurchase	-	1.15	0.5
Financing Cash Flow	3.99	1.15	0.5
Net Cash Flow	2.3	-0.31	-0.92
Free Cash Flow	-1.69	-1.46	-1.42

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).